Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2021 | Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare | Choon S.E.; Lebwohl M.G.; Marrakchi S.; Burden A.D.; TSEN-FANG TSAI ; Morita A.; Navarini A.A.; Zheng M.; Xu J.; Turki H.; Rajeswari S.; Deng H.; Tetzlaff K.; Thoma C.; Bachelez H. | BMJ Open | 50 | 37 |